Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Newly emerging metronidazole-resistant Clostridioides difficile PCR ribotype 955 identified in Poland, 2021 to 2023 but not in Czechia, 2012 to 2023 and Slovakia, 2015 to 2023

J. Zikova, K. Szarek, M. Kabała, D. Wultańska, N. Frankowska, A. Iwanicki, K. Hinc, A. Mucha, J. Komarnicka, A. Jagielska, E. Kuijper, M. Krutova, H. Pituch

. 2025 ; 30 (21) : . [pub] -

Language English Country Sweden

Document type Journal Article

BackgroundOn 29 January 2024, the European Centre for Disease Prevention and Control distributed an alert about a metronidazole-resistant Clostridioides difficile outbreak of PCR ribotype (RT) 955 in England.AimWe aimed to investigate the presence of RT955 in Czech, Slovak and Polish C. difficile isolates and evaluate different culture media for detecting its metronidazole resistance.MethodsIsolates with binary toxin genes identified as 'unknown' by the WEBRIBO PCR ribotyping database up to 2023 were re-analysed after adding the RT955 profile to the database. The RT955 isolates were characterised by whole genome sequencing and tested for susceptibility to 15 antimicrobials.ResultsWe did not find RT955 in Czech (n = 6,661, 2012-2023) and Slovak (n = 776, 2015-2023) isolates, but identified 13 RT955 cases (n = 303, 2021-2023) in three hospitals in Poland. By whole genome multilocus sequence typing, 10 isolates clustered into one clonal complex including a sequence of United Kingdom strain ERR12670107, and shared similar antimicrobial resistance genes/mutations. All 13 isolates were resistant to ciprofloxacin/moxifloxacin, erythromycin/clindamycin and ceftazidime. All isolates had a mutation in the nimB gene promoter and in NimB (Tyr130Ser and Leu155Ile). The metronidazole resistance was detected in all isolates using brain-heart-infusion agar supplemented with haemin and Chocolate agar. Results were discrepant with the European Committee on Antimicrobial Susceptibility Testing-recommended Fastidious anaerobe agar and Brucella blood agar.ConclusionThe identification of clonally related haem-dependent metronidazole-resistant C. difficile RT955 in multiple hospitals indicates a need for prospective surveillance to estimate its prevalence in Europe.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25015815
003      
CZ-PrNML
005      
20250731091238.0
007      
ta
008      
250708s2025 sw f 000 0|eng||
009      
AR
024    7_
$a 10.2807/1560-7917.ES.2025.30.21.2400675 $2 doi
035    __
$a (PubMed)40444372
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sw
100    1_
$a Zikova, Jaroslava $u Department of Medical Microbiology, Charles University Second Faculty of Medicine and Motol University Hospital, Prague, Czechia $u European Society for Clinical Microbiology and Infectious Diseases (ESGMID) study group for Clostridioides difficile (ESGCD), Basel, Switzerland
245    10
$a Newly emerging metronidazole-resistant Clostridioides difficile PCR ribotype 955 identified in Poland, 2021 to 2023 but not in Czechia, 2012 to 2023 and Slovakia, 2015 to 2023 / $c J. Zikova, K. Szarek, M. Kabała, D. Wultańska, N. Frankowska, A. Iwanicki, K. Hinc, A. Mucha, J. Komarnicka, A. Jagielska, E. Kuijper, M. Krutova, H. Pituch
520    9_
$a BackgroundOn 29 January 2024, the European Centre for Disease Prevention and Control distributed an alert about a metronidazole-resistant Clostridioides difficile outbreak of PCR ribotype (RT) 955 in England.AimWe aimed to investigate the presence of RT955 in Czech, Slovak and Polish C. difficile isolates and evaluate different culture media for detecting its metronidazole resistance.MethodsIsolates with binary toxin genes identified as 'unknown' by the WEBRIBO PCR ribotyping database up to 2023 were re-analysed after adding the RT955 profile to the database. The RT955 isolates were characterised by whole genome sequencing and tested for susceptibility to 15 antimicrobials.ResultsWe did not find RT955 in Czech (n = 6,661, 2012-2023) and Slovak (n = 776, 2015-2023) isolates, but identified 13 RT955 cases (n = 303, 2021-2023) in three hospitals in Poland. By whole genome multilocus sequence typing, 10 isolates clustered into one clonal complex including a sequence of United Kingdom strain ERR12670107, and shared similar antimicrobial resistance genes/mutations. All 13 isolates were resistant to ciprofloxacin/moxifloxacin, erythromycin/clindamycin and ceftazidime. All isolates had a mutation in the nimB gene promoter and in NimB (Tyr130Ser and Leu155Ile). The metronidazole resistance was detected in all isolates using brain-heart-infusion agar supplemented with haemin and Chocolate agar. Results were discrepant with the European Committee on Antimicrobial Susceptibility Testing-recommended Fastidious anaerobe agar and Brucella blood agar.ConclusionThe identification of clonally related haem-dependent metronidazole-resistant C. difficile RT955 in multiple hospitals indicates a need for prospective surveillance to estimate its prevalence in Europe.
650    _2
$a lidé $7 D006801
650    12
$a Clostridioides difficile $x genetika $x účinky léků $x izolace a purifikace $x klasifikace $7 D016360
650    12
$a ribotypizace $7 D021521
650    12
$a metronidazol $x farmakologie $7 D008795
650    12
$a klostridiové infekce $x epidemiologie $x mikrobiologie $x farmakoterapie $7 D003015
650    12
$a bakteriální léková rezistence $x genetika $7 D024881
650    12
$a antibakteriální látky $x farmakologie $7 D000900
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a polymerázová řetězová reakce $7 D016133
650    _2
$a sekvenování celého genomu $7 D000073336
650    _2
$a multilokusová sekvenční typizace $7 D058885
650    _2
$a epidemický výskyt choroby $7 D004196
651    _2
$a Polsko $x epidemiologie $7 D011044
651    _2
$a Slovenská republika $x epidemiologie $7 D018154
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Szarek, Klaudia $u Department of Medical Microbiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland
700    1_
$a Kabała, Monika $u Department of Medical Microbiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland
700    1_
$a Wultańska, Dorota $u Department of Medical Microbiology, Medical University of Warsaw, Warsaw, Poland
700    1_
$a Frankowska, Natalia $u Division of Molecular Bacteriology, Medical University of Gdańsk, Gdańsk, Poland $u Intercollegiate Faculty of Biotechnology, University of Gdańsk, Gdańsk, Poland
700    1_
$a Iwanicki, Adam $u Division of Molecular Bacteriology, Medical University of Gdańsk, Gdańsk, Poland
700    1_
$a Hinc, Krzysztof $u Division of Molecular Bacteriology, Medical University of Gdańsk, Gdańsk, Poland
700    1_
$a Mucha, Anna $u Department of Pulmonology with Oncology and Chemotherapy, Center of Pulmonology and Thoracic Surgery in Bystra, Poland
700    1_
$a Komarnicka, Jolanta $u Laboratory of Clinical Microbiology, University Centre for Laboratory Diagnostics, Medical University of Gdańsk Clinical Centre, Gdańsk, Poland
700    1_
$a Jagielska, Anna $u Department of Social Medicine and Public Health, Medical Faculty, Medical University of Warsaw, Warsaw, Poland
700    1_
$a Kuijper, Ed $u National Expertise Centre for Clostridioides difficile infections, Leiden University Center for Infectious Diseases, Leiden and Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands $u European Society for Clinical Microbiology and Infectious Diseases (ESGMID) study group for Clostridioides difficile (ESGCD), Basel, Switzerland
700    1_
$a Krutova, Marcela $u Department of Medical Microbiology, Charles University Second Faculty of Medicine and Motol University Hospital, Prague, Czechia $u European Society for Clinical Microbiology and Infectious Diseases (ESGMID) study group for Clostridioides difficile (ESGCD), Basel, Switzerland
700    1_
$a Pituch, Hanna $u Department of Medical Microbiology, Medical University of Warsaw, Warsaw, Poland
773    0_
$w MED00174364 $t Euro surveillance $x 1560-7917 $g Roč. 30, č. 21 (2025)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40444372 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731091232 $b ABA008
999    __
$a ok $b bmc $g 2366563 $s 1252940
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 30 $c 21 $e - $i 1560-7917 $m Euro surveillance $n Euro Surveill $x MED00174364
LZP    __
$a Pubmed-20250708

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...